Figure 2.
Bone marrow cellularity at baseline and at 12 months in a patient with trilineage responses to bone marrow‐derived mesenchymal stromal cells.
Bone marrow cellularity at baseline and at 12 months in a patient with trilineage responses to bone marrow‐derived mesenchymal stromal cells.